As reported, CML progression can be promoted by multiple pathways including RAS, PI3K/AKT, ERK, MYC, JAK/STAT, myeloid differentiation, apoptosis, cell cycle, and genomic instability (39). The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.